{"result": "{\n    \"title\": \"EGDT and Sepsis Management Trials\",\n    \"summary\": \"The community centers around Early Goal-Directed Therapy (EGDT) and its evaluation through various clinical trials such as the ProCESS, ARISE, and ProMISe trials. These trials aim to assess the effectiveness of EGDT in managing septic shock compared to usual care and other protocol-based therapies. Key entities include the EGDT and Usual-Care groups, the Emergency Department, and organizations like Edwards Lifesciences, which provided essential equipment for the trials.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the significant implications of EGDT on clinical practices and patient outcomes in septic shock management.\",\n    \"findings\": [\n        {\n            \"summary\": \"Role of EGDT in septic shock management\",\n            \"explanation\": \"Early Goal-Directed Therapy (EGDT) is a protocol-based resuscitation strategy designed to improve outcomes in patients with septic shock. It involves intensive monitoring and specific interventions, such as the use of central venous catheters and vasoactive drugs, to optimize hemodynamic parameters [Data: Entities (258); Relationships (141, 329, 719, 721, 722, +more)]. EGDT has been a focal point in several clinical trials, including the ProCESS, ARISE, and ProMISe trials, which aim to evaluate its effectiveness compared to usual care and other resuscitation strategies [Data: Entities (247, 270, 271); Relationships (687, 709, 710, 713, +more)].\"\n        },\n        {\n            \"summary\": \"Significance of the ProCESS, ARISE, and ProMISe trials\",\n            \"explanation\": \"The ProCESS, ARISE, and ProMISe trials are multicenter studies conducted in different regions to assess the effectiveness of EGDT in managing septic shock. The ProCESS trial, conducted in the United States, compared EGDT with usual care and protocol-based standard therapy, reporting lower-than-anticipated mortality rates [Data: Entities (247); Relationships (142, 687, 684, +more)]. The ARISE trial, conducted in Australasia, and the ProMISe trial, conducted in the United Kingdom, also evaluated EGDT, contributing valuable insights into its impact on patient outcomes [Data: Entities (270, 271); Relationships (143, 144, 709, 710, 766, +more)].\"\n        },\n        {\n            \"summary\": \"Comparison between EGDT and Usual-Care groups\",\n            \"explanation\": \"The clinical trials involved comparing the EGDT group with the Usual-Care group to evaluate the effectiveness of protocol-based interventions. The EGDT group received structured treatment protocols, including continuous ScvO2 monitoring and the use of vasoactive drugs, while the Usual-Care group received standard treatment practices without protocol prompts [Data: Entities (262, 264); Relationships (719, 742, 700, 758, +more)]. The trials aimed to assess differences in mortality and other outcomes between these groups, providing insights into the potential benefits of EGDT [Data: Relationships (728, 762, 763, 764, +more)].\"\n        },\n        {\n            \"summary\": \"Involvement of Edwards Lifesciences\",\n            \"explanation\": \"Edwards Lifesciences played a crucial role in the trials by providing ScvO2 monitors and technical support to participating sites. This involvement was essential for the implementation of EGDT, as continuous ScvO2 monitoring is a key component of the protocol [Data: Entities (244); Relationships (679, 678, 680, +more)]. The company's contribution ensured the effective use of their equipment during the trials, highlighting the importance of industry collaboration in clinical research [Data: Relationships (681, 682)].\"\n        },\n        {\n            \"summary\": \"Impact of EGDT on clinical practices\",\n            \"explanation\": \"The findings from the EGDT trials have significant implications for clinical practices in managing septic shock. The trials demonstrated the potential benefits of protocol-based resuscitation strategies, influencing guidelines and treatment protocols in hospitals worldwide [Data: Relationships (467, 714, 700, +more)]. The Surviving Sepsis Campaign, for instance, endorses EGDT as a key strategy to reduce mortality in septic shock patients, underscoring its impact on improving patient outcomes [Data: Relationships (467, 714)].\"\n        }\n    ]\n}", "input": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n258,EGDT,\"Early Goal-Directed Therapy (EGDT) is a protocol-based resuscitation strategy used in the management of septic shock and severe sepsis. It focuses on optimizing hemodynamic parameters to improve patient outcomes. EGDT involves intensive monitoring and specific interventions, including the insertion of central venous catheters, administration of intravenous fluids, vasoactive drugs, and red-cell transfusions. The protocol also includes monitoring serum lactate levels and central venous oxygen saturation (ScvO2). EGDT is being tested in clinical trials for its effectiveness in managing patients with early septic shock, aiming to enhance resuscitation efforts and improve survival rates.\",51\n247,PROCESS TRIAL,\"The ProCESS trial, also known as the Protocolized Care for Early Septic Shock trial, is a multicenter, randomized clinical trial conducted in the United States. It was designed to evaluate the effectiveness of protocol-based care, specifically Early Goal-Directed Therapy (EGDT), versus usual care in patients with severe conditions, particularly those experiencing septic shock. The trial aimed to assess the outcomes of protocol-based resuscitation in these patients and reported lower-than-anticipated mortality rates.\",11\n257,EMERGENCY DEPARTMENT,\"The Emergency Department is a critical hospital location where patients are initially assessed, particularly for studies and trials. It is a medical treatment facility specializing in the acute care of patients who present without prior appointments, including those suffering from severe conditions such as septic shock. In the context of the study, the Emergency Department served as the section of the hospital where patients received their initial treatment. It was also the location where the duration of patients' stays was compared between different treatment groups. Additionally, it was the place where patients with severe sepsis or septic shock were initially assessed and randomly assigned to treatment groups for enrollment in the trial.\",8\n270,ARISE TRIAL,\"The ARISE TRIAL, known as the Australasian Resuscitation in Sepsis Evaluation trial, is a multicenter study conducted in Australasia, specifically in Australia. The trial focuses on evaluating Early Goal-Directed Therapy (EGDT) in patients experiencing septic shock. Notably, the ARISE TRIAL reported lower-than-anticipated mortality rates, contributing valuable insights into the management of septic shock.\",3\n271,PROMISE TRIAL,The Protocolised Management in Sepsis (ProMISe) trial is a multicenter study conducted in the United Kingdom. It is designed to investigate and assess the effectiveness of Early Goal-Directed Therapy (EGDT) in the management of septic shock.,3\n264,USUAL-CARE GROUP,\"The USUAL-CARE GROUP is a cohort of patients involved in a clinical trial designed to assess the effectiveness of standard treatment practices for patients. This group serves as the control group in the study, receiving standard care without the specific interventions of Early Goal-Directed Therapy (EGDT). The focus of the study is on usual care practices for patients, particularly those with septic shock. Initially, 804 patients were assigned to the USUAL-CARE GROUP, and 796 of them completed the study.\",18\n262,EGDT GROUP,\"The EGDT group is a cohort of patients involved in a clinical study to assess the effectiveness of Early Goal-Directed Therapy (EGDT), a protocol-based treatment strategy. This group initially consisted of 796 patients, with 792 completing the study. The focus of the EGDT group is on managing patients' physiological and laboratory values through a structured treatment protocol.\",16\n468,PROMISE STUDY,\"A pragmatic, randomized trial conducted in England to evaluate the effectiveness of EGDT in patients with early septic shock\",7\n244,EDWARDS LIFESCIENCES,\"Edwards Lifesciences is a company based in Irvine, California, that specializes in providing medical devices, particularly for monitoring central venous oxygen saturation (ScvO2). In the context of a study, Edwards Lifesciences played a crucial role by loaning ScvO2 monitors to participating sites. Additionally, the company provided essential training and technical support to ensure the effective use of their equipment during the trial.\",5\n248,RIVERS ET AL.,\"Rivers et al. refers to a group of researchers who conducted a landmark study in 2001 on early goal-directed therapy (EGDT) for patients with severe sepsis or septic shock. Their research demonstrated the efficacy of early, goal-directed resuscitation, reporting lower mortality rates in these patients. The study by Rivers et al. is frequently referenced for comparison in subsequent studies, and their protocol has been mimicked in protocol-based EGDT interventions. Additionally, Rivers et al. conducted a study on adherence to the EGDT protocol, further solidifying their contribution to the field of sepsis treatment.\",5\n266,CENTRAL VENOUS CATHETER,A central venous catheter is a medical device used in the Early Goal-Directed Therapy (EGDT) group for continuous monitoring of central venous oxygen saturation (ScvO2). The insertion and placement of a central venous catheter is a procedure performed on patients within the study to facilitate this continuous ScvO2 monitoring.,4\n267,SCVO2,\"SCVO2 refers to central venous oxygen saturation, a parameter monitored in the EGDT group.\",4\n478,ENGLAND,\"England is the country where a study involving adults with early signs of septic shock was conducted. This study took place in NHS hospitals, focusing on patients experiencing septic shock.\",4\n480,ENGLISH NHS HOSPITALS,The study was conducted in English NHS hospitals that did not routinely use EGDT with continuous ScvO2 monitoring,3\n474,NHS,\"The National Health Service (NHS) is the publicly funded healthcare system of England, where the study was conducted.\",3\n500,ARISE,\"The ARISE trial is another study that assessed the impact of EGDT on septic shock, conducted in Australasia\",2\n309,DOBUTAMINE,\"Dobutamine is a medication used to treat heart failure and improve cardiac output. It is administered as a treatment to manage cardiac output in patients, as demonstrated in various studies.\",2\n260,INTENTION-TO-TREAT PRINCIPLE,\"The \"\"INTENTION-TO-TREAT PRINCIPLE\"\" is a methodological approach used in the analysis of study data. It ensures that all patients are analyzed in the groups to which they were originally randomized, regardless of whether they completed the treatment. This principle is applied to maintain the integrity of the initial treatment assignment and to provide an unbiased estimate of the treatment effect.\",2\n475,SSC,,2\n486,TEACHING HOSPITALS,\"Teaching hospitals are medical institutions involved in the study, accounting for 29% of the 56 sites where patients were screened\",2\n490,MORTALITY AT 90 DAYS,\"Mortality at 90 days refers to the death rate of patients within 90 days of treatment, used as a primary outcome measure in the study\",2\n491,INTRAVENOUS FLUIDS,Intravenous fluids are administered to patients to maintain fluid balance and treat dehydration or shock,2\n493,INTRAVENOUS CRYSTALLOIDS,Intravenous crystalloids are solutions used to replace lost fluids and electrolytes in patients,2\n495,VASOPRESSORS,\"Vasopressors are medications used to support and raise blood pressure in critically ill patients, particularly those experiencing severe hypotension. These medications are crucial in medical studies and treatments aimed at stabilizing patients with dangerously low blood pressure levels.\",2\n242,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,\"The National Institute of General Medical Sciences, a part of the National Institutes of Health, supports research aimed at increasing the understanding of biological processes. This foundational work is crucial for advancing disease diagnosis, treatment, and prevention. Additionally, the institute is known for funding significant research initiatives, such as the ProCESS trial.\",2\n253,PROTOCOL-BASED STANDARD THERAPY,\"PROTOCOL-BASED STANDARD THERAPY is a treatment strategy used in a study as a comparison to Early Goal-Directed Therapy (EGDT) and usual care. This intervention involves less aggressive resuscitation instructions than EGDT, utilizing peripheral venous access for the administration of fluids and vasoactive agents.\",2\n254,USUAL CARE,\"USUAL CARE refers to the standard medical treatment provided to patients in the study, serving as the control group. In this context, bedside providers directed all care without protocol prompts, distinguishing it from the specific protocol-based interventions of Early Goal-Directed Therapy (EGDT). As the standard treatment protocol, USUAL CARE is used as a benchmark against which EGDT is being compared in the trial.\",2\n259,BRESLOW–DAY TEST,A statistical test used in the study to assess the homogeneity of odds ratios across different subgroups,1\n261,MARCH 2008 THROUGH MAY 2013,,1\n269,JONES ET AL.,Jones et al. refers to a group of researchers who conducted a randomized trial comparing different EGDT protocols,1\n313,PROCESS STUDY,\"A study that investigated the effectiveness of protocol-based resuscitation in patients with septic shock, similar to the EGDT trial\",1\n481,SEQUENTIAL ORGAN FAILURE ASSESSMENT (SOFA),The SOFA score was used as a secondary outcome measure in the study to assess organ failure,1\n482,EUROPEAN QUALITY OF LIFE–5 DIMENSIONS (EQ-5D),The EQ-5D five-level questionnaire was used to measure health-related quality of life in the study,1\n483,ICNARC CASE MIX PROGRAM DATABASE,The ICNARC Case Mix Program Database was used to estimate 90-day mortality rates for the study,1\n488,SYSTOLIC BLOOD PRESSURE,\"Systolic blood pressure is the pressure in the arteries when the heart beats, indicating cardiovascular health\",1\n489,HEMOGLOBIN,\"Hemoglobin is a protein in red blood cells that carries oxygen, used to assess anemia and overall health\",1\n492,INTRAVENOUS COLLOIDS,Intravenous colloids are solutions used to increase blood volume and pressure in patients,1\n494,RED-CELL TRANSFUSIONS,Red-cell transfusions involve the transfer of red blood cells to a patient to treat anemia or blood loss,1\n496,PLATELETS,\"Platelets are blood components involved in clotting, administered to patients to prevent or treat bleeding\",1\n263,STANDARD-THERAPY GROUP,\"The STANDARD-THERAPY GROUP is a protocol-based treatment group involved in a clinical trial designed to assess the effectiveness of a specific treatment protocol for patients. This group focuses on administering standard therapy within the context of the clinical study, adhering to established protocols to evaluate treatment outcomes.\",5\n265,RESUSCITATION,Resuscitation refers to the process of administering intravenous fluids and other treatments to stabilize patients in the study,3\n306,KAPLAN–MEIER METHOD,The Kaplan–Meier method is a statistical measure used to estimate survival time from randomization to 90 days in the study,2\n497,FRESH-FROZEN PLASMA,Fresh-frozen plasma is used to treat patients with clotting disorders or massive blood loss,1\n307,VASOPRESSOR INFUSION,The administration of vasopressor infusion is a treatment used in the study to manage blood pressure in patients,1\n308,RED-CELL TRANSFUSION,The administration of red-cell transfusion is a medical procedure used in the study to manage patients' hemoglobin levels,1\n310,WITHDRAWAL OF THERAPY,The withdrawal of therapy is a decision made during the study to stop treatment for certain patients in the EGDT group,1\n311,TRANSFER TO THE OPERATING ROOM,The transfer to the operating room is a procedure performed during the study for certain patients in the EGDT group,1\n312,INTERHOSPITAL TRANSFER,The interhospital transfer is a procedure performed during the study for certain patients in the EGDT group,1\n250,PARTICIPATING SITES,\"Academic hospitals involved in the study, each with more than 40,000 emergency department visits yearly\",5\n249,EARLY GOAL-DIRECTED THERAPY (EGDT),,2\n245,CRISMA CENTER,\"The University of Pittsburgh Clinical Research, Investigation, and Systems Modeling of Acute Illness Center that managed data for the trial\",1\n268,SERUM LACTATE LEVEL,\"A clinical measurement used to assess the severity of shock in patients, referenced in the study for subgroup analysis\",1\n243,UNIVERSITY OF PITTSBURGH,The institution that managed the data for the ProCESS trial and had its institutional review board approve the study,1\n471,NORTH WEST LONDON RESEARCH ETHICS COMMITTEE,\"The North West London Research Ethics Committee is responsible for approving the study protocol for the trial, including the ProMISe study protocol.\",2\n476,ICNARC,,1\n473,NIHR,,1\n252,PROTOCOL-BASED EGDT,\"A study intervention involving protocol-guided resuscitation interventions, including central venous catheter placement and administration of fluids and vasopressors\",2\n256,CENTRALIZED WEB-BASED PROGRAM,The system used for randomization of patients in the study,1\n510,IRVINE,Irvine is a city in California where Edwards Lifesciences is located,1\n255,PROCESS INVESTIGATORS,Researchers who designed the protocol-based standard-therapy approach based on literature review and surveys,2\n501,AUSTRALASIA,\"Region where the ARISE trial, a study similar to the one described, was conducted\",1\n477,RIVERS ET AL. STUDY,\"A 2001 single-center, proof-of-concept study that influenced the SSC guidelines for EGDT\",1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,rank\n141,SEPTIC SHOCK,EGDT,\"EGDT, or Early Goal-Directed Therapy, is a treatment protocol specifically designed for the management of septic shock. It is aimed at improving outcomes in patients who are experiencing early septic shock. This protocol is utilized to guide the management of septic shock, ensuring that patients receive timely and appropriate interventions to enhance their chances of recovery.\",121\n329,ICU,EGDT,\"Early Goal-Directed Therapy (EGDT) was implemented in the Intensive Care Unit (ICU) as part of a trial aimed at treating patients with early septic shock. Patients in the EGDT group were assessed for potential admission to the ICU, and those receiving EGDT were more frequently admitted to the ICU. This approach highlights the integration of EGDT within the ICU setting to enhance the management of early septic shock.\",97\n142,SEPTIC SHOCK,PROCESS TRIAL,The ProCESS trial evaluated the effectiveness of EGDT in patients with septic shock,81\n145,SEPTIC SHOCK,EMERGENCY DEPARTMENT,Patients with septic shock often present to the emergency department for immediate care,78\n143,SEPTIC SHOCK,ARISE TRIAL,The ARISE trial is investigating EGDT in patients with septic shock,73\n144,SEPTIC SHOCK,PROMISE TRIAL,The ProMISe trial is investigating EGDT in patients with septic shock,73\n719,EGDT,USUAL-CARE GROUP,\"The research study involves two groups, the EGDT group and the usual-care group, which are compared to evaluate the effectiveness of the EGDT protocol. The study specifically examines the outcomes of patients receiving Early Goal-Directed Therapy (EGDT) in comparison to those receiving usual care.\",69\n434,SUPPLEMENTARY APPENDIX,EGDT,The Supplementary Appendix contains additional figures and tables related to the study involving EGDT,67\n544,DATA AND SAFETY MONITORING BOARD,EGDT,The data and safety monitoring board was consulted during the study involving EGDT,65\n328,ICU,USUAL-CARE GROUP,\"The usual-care group consisted of patients who were assessed for potential admission to the ICU. A significant number of these patients were admitted directly to the ICU, indicating a close monitoring and evaluation process to determine the necessity of intensive care for individuals in this group.\",64\n687,PROCESS TRIAL,EGDT,\"The ProCESS trial evaluated protocol-based resuscitation, including Early Goal-Directed Therapy (EGDT), in patients with septic shock. This trial specifically assessed the effectiveness of EGDT in managing septic shock within the United States.\",62\n327,ICU,EGDT GROUP,A significant number of patients in the EGDT group were admitted directly to the ICU,62\n351,INTENSIVE CARE UNIT (ICU),EGDT,The Intensive Care Unit is one of the locations where EGDT was implemented,61\n711,EGDT,ARISE STUDY,The ARISE study was designed to test the hypothesis that EGDT would decrease 90-day all-cause mortality among patients with early septic shock,60\n467,SURVIVING SEPSIS CAMPAIGN,EGDT,\"The Surviving Sepsis Campaign is an initiative aimed at reducing mortality in patients with sepsis and septic shock. One of the key strategies endorsed by the campaign is Early Goal-Directed Therapy (EGDT), which is specifically designed to decrease mortality in patients suffering from septic shock. Although the decline in in-hospital mortality for septic shock began before the introduction of the Surviving Sepsis Campaign, the campaign has continued to promote EGDT as an essential component of its efforts to improve patient outcomes.\",60\n566,SOFA SCORE,EGDT,The SOFA score was used to assess patients in the EGDT group,59\n701,EMERGENCY DEPARTMENT,EGDT,\"The Emergency Department is one of the locations where Early Goal-Directed Therapy (EGDT) was implemented. EGDT was introduced in the emergency department as part of a trial aimed at treating patients with early septic shock. Patients initially presented at the emergency department before being randomized into the EGDT group, highlighting the department's critical role in the early intervention and management of septic shock through this therapeutic approach.\",59\n713,EGDT,PROMISE STUDY,The ProMISe study tested the effectiveness of the EGDT protocol in patients with early septic shock,58\n679,EDWARDS LIFESCIENCES,EGDT,Edwards Lifesciences provided ScvO2 monitors used in the EGDT treatment protocol,56\n419,FISHER'S EXACT TEST,EGDT,Fisher's exact test was used to analyze the primary outcome of the study involving EGDT,56\n690,RIVERS ET AL.,EGDT,\"Rivers et al. conducted a study focusing on the adherence to the Early Goal-Directed Therapy (EGDT) protocol. This study also involved a comparative analysis of its findings on EGDT with those from a 2001 study by Rivers et al., providing insights into the evolution and implementation of the EGDT protocol over time.\",56\n721,EGDT,CENTRAL VENOUS CATHETER,Central venous catheters were used in the EGDT group for continuous ScvO2 monitoring,55\n722,EGDT,SCVO2,ScvO2 was continuously monitored in the EGDT group using central venous catheters,55\n723,EGDT,ENGLAND,The study on EGDT was conducted in England,55\n709,EGDT,ARISE TRIAL,The ARISE trial is a study conducted in Australasia that evaluates the effectiveness of Early Goal-Directed Therapy (EGDT) in the treatment of septic shock.,54\n710,EGDT,PROMISE TRIAL,The ProMISe trial is a research study designed to investigate and assess the effectiveness of Early Goal-Directed Therapy (EGDT) in the management of septic shock.,54\n715,EGDT,ENGLISH NHS HOSPITALS,The study was conducted in English NHS hospitals using the EGDT protocol,54\n724,EGDT,CENTRAL VENOUS PRESSURE,Central venous pressure was measured more frequently in the EGDT group,54\n725,EGDT,MEAN ARTERIAL PRESSURE,Mean arterial pressure was a parameter monitored in the EGDT group,54\n736,EGDT,NHS,The study on EGDT was conducted in NHS hospitals in England,54\n482,SAS SOFTWARE,EGDT,SAS software was used to perform statistical analyses for the study involving EGDT,54\n606,KAPLAN–MEIER ESTIMATES,EGDT,Kaplan–Meier estimates were used to analyze survival data in the study involving EGDT,54\n738,EGDT,ARISE,The study's findings on EGDT were compared with those of the ARISE trial,53\n734,EGDT,DOBUTAMINE,The use of dobutamine was higher in the EGDT group,53\n707,EGDT,INTENTION-TO-TREAT PRINCIPLE,The intention-to-treat principle was used to analyze data in the study involving EGDT,53\n714,EGDT,SSC,The SSC promotes the use of EGDT as part of best practices for sepsis treatment,53\n720,EGDT,TEACHING HOSPITALS,Teaching hospitals were among the sites where patients were screened and enrolled in the EGDT group,53\n728,EGDT,MORTALITY AT 90 DAYS,The study measured mortality at 90 days as a primary outcome for the EGDT group,53\n729,EGDT,INTRAVENOUS FLUIDS,Patients in the EGDT group received intravenous fluids,53\n731,EGDT,INTRAVENOUS CRYSTALLOIDS,Patients in the EGDT group received intravenous crystalloids,53\n733,EGDT,VASOPRESSORS,The use of vasopressors was higher in the EGDT group,53\n737,EGDT,PROCESS,The study's findings on EGDT were compared with those of the ProCESS trial,53\n676,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,EGDT,The National Institute of General Medical Sciences was consulted regarding the study design involving EGDT,53\n699,PROTOCOL-BASED STANDARD THERAPY,EGDT,Protocol-based standard therapy was compared to EGDT in the study,53\n700,USUAL CARE,EGDT,\"In the trial, Early Goal-Directed Therapy (EGDT) is being compared to Usual Care to evaluate its effectiveness. The study specifically aims to assess differences in mortality among patients experiencing early septic shock. Usual Care serves as the control group in this comparison with EGDT.\",53\n705,EGDT,BRESLOW–DAY TEST,The Breslow–Day test was used to assess interactions between treatment assignment and subgroups in the study involving EGDT,52\n706,EGDT,MARCH 2008 THROUGH MAY 2013,The study involving EGDT enrolled patients during this time period,52\n708,EGDT,JONES ET AL.,Jones et al. conducted a trial comparing different EGDT protocols,52\n712,EGDT,PROCESS STUDY,Both the EGDT trial and the ProCESS study investigated the effectiveness of protocol-based resuscitation in septic shock,52\n716,EGDT,SEQUENTIAL ORGAN FAILURE ASSESSMENT (SOFA),The SOFA score was used to assess outcomes in patients receiving EGDT,52\n717,EGDT,EUROPEAN QUALITY OF LIFE–5 DIMENSIONS (EQ-5D),The EQ-5D was used to measure quality of life in patients receiving EGDT,52\n718,EGDT,ICNARC CASE MIX PROGRAM DATABASE,The ICNARC Case Mix Program Database was used to estimate mortality rates for patients receiving EGDT,52\n726,EGDT,SYSTOLIC BLOOD PRESSURE,Systolic blood pressure was a parameter monitored in the EGDT group,52\n727,EGDT,HEMOGLOBIN,Hemoglobin levels were monitored in the EGDT group,52\n730,EGDT,INTRAVENOUS COLLOIDS,More patients in the EGDT group received intravenous colloids,52\n732,EGDT,RED-CELL TRANSFUSIONS,More patients in the EGDT group received red-cell transfusions,52\n735,EGDT,PLATELETS,The volume of platelets administered was larger in the EGDT group,52\n742,EGDT GROUP,USUAL-CARE GROUP,\"The EGDT Group and the Usual-Care Group are two cohorts involved in a clinical study designed to compare different treatment protocols. Specifically, the study evaluates the effectiveness of Early Goal-Directed Therapy (EGDT) by comparing the outcomes of the EGDT Group with those of the Usual-Care Group. Both groups are integral to the study's aim of assessing the benefits and potential advantages of implementing early goal-directed therapy over usual care practices.\",34\n411,ARDS,VASOPRESSORS,Vasopressors were used to support blood pressure in patients with ARDS,34\n34,APACHE II,USUAL-CARE GROUP,APACHE II scores were used as a baseline covariate in the analysis of the usual-care group,29\n254,SAS INSTITUTE,USUAL-CARE GROUP,SAS software from SAS Institute was used to analyze data from the usual-care group,29\n33,APACHE II,EGDT GROUP,APACHE II scores were used as a baseline covariate in the analysis of the EGDT group,27\n253,SAS INSTITUTE,EGDT GROUP,SAS software from SAS Institute was used to analyze data from the EGDT group,27\n703,EMERGENCY DEPARTMENT,USUAL-CARE GROUP,\"Patients in the usual-care group were initially presented at the emergency department, where they were subsequently randomized into the group.\",26\n567,SOFA SCORE,USUAL-CARE GROUP,The SOFA score was used to assess patients in the usual-care group,26\n702,EMERGENCY DEPARTMENT,EGDT GROUP,Patients in the EGDT group were presented and randomized at the emergency department,24\n753,STANDARD-THERAPY GROUP,USUAL-CARE GROUP,\"The STANDARD-THERAPY GROUP and the USUAL-CARE GROUP are both part of a clinical study designed to compare different treatment protocols. In this clinical trial, the standard-therapy group is directly compared with the usual-care group to evaluate the effectiveness and outcomes of the respective treatment approaches.\",23\n758,USUAL-CARE GROUP,CENTRAL VENOUS CATHETER,\"In the usual-care group, a significant number of patients had central venous catheters inserted. However, these catheters were placed later compared to the patients in the EGDT group.\",22\n761,USUAL-CARE GROUP,ENGLAND,The study on the usual-care group was conducted in England,22\n235,UNITED STATES,PROCESS TRIAL,The ProCESS trial was conducted in 31 emergency departments across the United States,22\n757,USUAL-CARE GROUP,SCVO2,The usual-care group had a lower percentage of patients with ScvO2 monitoring compared to the EGDT group,22\n741,EGDT GROUP,STANDARD-THERAPY GROUP,\"The EGDT GROUP and the STANDARD-THERAPY GROUP are both integral components of a clinical study that is focused on comparing different treatment protocols. These groups are involved in protocol-based care as part of the clinical trial, highlighting their role in evaluating and contrasting the effectiveness of various therapeutic approaches.\",21\n756,USUAL-CARE GROUP,RESUSCITATION,The usual-care group received resuscitation involving intravenous fluids and other treatments,21\n744,EGDT GROUP,CENTRAL VENOUS CATHETER,\"The EGDT group had central venous catheters placed promptly in a majority of patients. These catheters were inserted to monitor central venous oxygen saturation, providing essential data for the management and treatment of patients within the group.\",20\n743,EGDT GROUP,SCVO2,The EGDT group had a high percentage of patients with ScvO2 monitoring through central venous catheters,20\n764,USUAL-CARE GROUP,INTRAVENOUS CRYSTALLOIDS,Patients in the usual-care group received intravenous crystalloids,20\n763,USUAL-CARE GROUP,INTRAVENOUS FLUIDS,Patients in the usual-care group received intravenous fluids,20\n759,USUAL-CARE GROUP,KAPLAN–MEIER METHOD,The Kaplan–Meier method was used to calculate survival time for the usual-care group,20\n762,USUAL-CARE GROUP,MORTALITY AT 90 DAYS,The study measured mortality at 90 days as a primary outcome for the usual-care group,20\n760,USUAL-CARE GROUP,TEACHING HOSPITALS,Teaching hospitals were among the sites where patients were screened and enrolled in the usual-care group,20\n740,EGDT GROUP,RESUSCITATION,\"The EGDT group received a specific protocol of resuscitation involving intravenous fluids, vasopressors, and other treatments\",19\n765,USUAL-CARE GROUP,FRESH-FROZEN PLASMA,The volume of fresh-frozen plasma administered was higher in the usual-care group,19\n115,APACHE II SCORE,PROCESS TRIAL,The ProCESS trial used the APACHE II score to analyze subgroups of patients based on illness severity,19\n748,EGDT GROUP,DOBUTAMINE,More patients in the EGDT group received dobutamine compared to the usual-care group,18\n745,EGDT GROUP,KAPLAN–MEIER METHOD,The Kaplan–Meier method was used to calculate survival time for the EGDT group,18\n746,EGDT GROUP,VASOPRESSOR INFUSION,More patients in the EGDT group received vasopressor infusion compared to the usual-care group,17\n747,EGDT GROUP,RED-CELL TRANSFUSION,More patients in the EGDT group received red-cell transfusion compared to the usual-care group,17\n749,EGDT GROUP,WITHDRAWAL OF THERAPY,Withdrawal of therapy was a reason for stopping EGDT prematurely in some patients,17\n750,EGDT GROUP,TRANSFER TO THE OPERATING ROOM,Transfer to the operating room was a reason for stopping EGDT prematurely in some patients,17\n751,EGDT GROUP,INTERHOSPITAL TRANSFER,Interhospital transfer was a reason for stopping EGDT prematurely in some patients,17\n266,HOSPITAL,EMERGENCY DEPARTMENT,The emergency department is a part of the hospital where initial patient treatment and comparisons of stay duration were conducted,17\n691,RIVERS ET AL.,CONSERVATIVE-STRATEGY GROUP,\"Rivers et al. demonstrated early resuscitation efficacy, contrasting with the conservative-strategy group's later intervention\",17\n71,AUSTRALIA,ARISE TRIAL,The ARISE trial is being conducted in Australia,16\n678,EDWARDS LIFESCIENCES,PROCESS TRIAL,Edwards Lifesciences provided ScvO2 monitoring equipment for the ProCESS trial,16\n685,PROCESS TRIAL,RIVERS ET AL.,\"The ProCESS trial was conducted to test the findings of Rivers et al. regarding Early Goal-Directed Therapy (EGDT). The results of the ProCESS trial are compared with those of the study conducted by Rivers et al., providing a comprehensive analysis of EGDT's effectiveness.\",16\n625,INTENSIVE CARE UNIT,EMERGENCY DEPARTMENT,Patients were initially assessed in the emergency department before potential admission to the intensive care unit,14\n466,SURVIVING SEPSIS CAMPAIGN,PARTICIPATING SITES,The participating sites adhered to the Surviving Sepsis Campaign guidelines for nonresuscitation aspects of care,14\n684,PROCESS TRIAL,EARLY GOAL-DIRECTED THERAPY (EGDT),The ProCESS trial tested the effectiveness of EGDT compared to other resuscitation strategies,13\n694,PARTICIPATING SITES,EMERGENCY DEPARTMENT,The emergency department is a part of the participating sites where patients were recruited,13\n354,INTENSIVE CARE UNIT (ICU),ENGLISH NHS HOSPITALS,The ICU is a part of English NHS hospitals where study patients may have been treated,13\n675,NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES,PROCESS TRIAL,The National Institute of General Medical Sciences funded the ProCESS trial,13\n683,CRISMA CENTER,PROCESS TRIAL,The CRISMA Center managed data for the ProCESS trial,12\n680,EDWARDS LIFESCIENCES,PROMISE STUDY,\"Edwards Lifesciences is mentioned in the context of the ProMISe study, possibly as a collaborator or equipment provider\",12\n686,PROCESS TRIAL,SERUM LACTATE LEVEL,The ProCESS trial used serum lactate levels to analyze subgroups of patients based on shock severity,12\n677,UNIVERSITY OF PITTSBURGH,PROCESS TRIAL,The University of Pittsburgh managed the data for the ProCESS trial,12\n704,EMERGENCY DEPARTMENT,ENGLISH NHS HOSPITALS,The Emergency Department is a part of English NHS hospitals where patients were initially assessed,11\n948,PROMISE STUDY,ENGLAND,The ProMISe study was conducted in hospitals across England,11\n692,PARTICIPATING SITES,WRITING COMMITTEE,The writing committee ensured the accuracy and completeness of data from the participating sites,11\n945,PROMISE STUDY,NHS,The ProMISe study was conducted in NHS emergency departments in England,10\n755,STANDARD-THERAPY GROUP,CENTRAL VENOUS CATHETER,The standard-therapy group had central venous catheters placed later than the EGDT group,9\n681,EDWARDS LIFESCIENCES,CLINICAL TRIALS UNIT,Edwards Lifesciences provided equipment and support for the study managed by the Clinical Trials Unit,9\n946,PROMISE STUDY,NORTH WEST LONDON RESEARCH ETHICS COMMITTEE,The North West London Research Ethics Committee approved the ProMISe study protocol,9\n766,PROMISE TRIAL,UNITED KINGDOM,The ProMISe trial is being conducted in the United Kingdom,9\n754,STANDARD-THERAPY GROUP,SCVO2,The standard-therapy group had a lower percentage of patients with ScvO2 monitoring compared to the EGDT group,9\n947,PROMISE STUDY,ICNARC,ICNARC managed the ProMISe study,8\n944,PROMISE STUDY,NIHR,The NIHR funded the ProMISe study,8\n752,STANDARD-THERAPY GROUP,RESUSCITATION,The standard-therapy group received a specific protocol of resuscitation involving intravenous fluids and other treatments,8\n688,RIVERS ET AL.,EARLY GOAL-DIRECTED THERAPY (EGDT),Rivers et al. reported the effectiveness of EGDT in reducing mortality in 2001,7\n949,NHS,ENGLAND,The NHS is the healthcare system in England where the study was conducted,7\n739,INTENTION-TO-TREAT PRINCIPLE,SOAP STUDY,The SOAP study data were analyzed according to the intention-to-treat principle,7\n693,PARTICIPATING SITES,USUAL CARE,Usual care was one of the interventions implemented at the participating sites,7\n689,RIVERS ET AL.,PROTOCOL-BASED EGDT,The protocol-based EGDT intervention was designed to mimic the protocol used by Rivers et al.,7\n695,PARTICIPATING SITES,CENTRALIZED WEB-BASED PROGRAM,The centralized web-based program was used for randomization at the participating sites,6\n682,EDWARDS LIFESCIENCES,IRVINE,\"Edwards Lifesciences is located in Irvine, California\",6\n942,UNITED KINGDOM NATIONAL INSTITUTE FOR HEALTH RESEARCH (NIHR),NORTH WEST LONDON RESEARCH ETHICS COMMITTEE,The North West London Research Ethics Committee approved the study protocol funded by the NIHR,5\n697,PROTOCOL-BASED EGDT,PROCESS INVESTIGATORS,The ProCESS investigators designed the protocol-based EGDT intervention,4\n698,PROTOCOL-BASED STANDARD THERAPY,PROCESS INVESTIGATORS,The ProCESS investigators designed the protocol-based standard-therapy intervention,4\n957,ARISE,AUSTRALASIA,\"The ARISE trial, similar to the study described, was conducted in Australasia\",3\n950,SSC,RIVERS ET AL. STUDY,The Rivers et al. study influenced the SSC guidelines for EGDT,3\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "parameters": {"model": "gpt-4o", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 2000, "n": 1}, "history": null}